Segmented Nucleic Acid Detection Arrays for Cross-Contamination Monitoring

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Cross-contamination between samples on multi-sector microarrays leads to unreliable data due to mixing of fluids and reagents, compromising the quality and reliability of detection results.

Innovation Solution

A nucleic acid or peptide detection system with alternating areas containing single-stranded acceptor and donor control nucleic acids covalently or polycationically attached to a carrier, allowing detection of cross-contamination through hybridization of donor and acceptor control nucleic acids upon contact.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If multiple samples are processed in parallel on a multi-sector array, then productivity is improved, but cross-contamination occurs between samples causing data reliability to deteriorate

Engineering Contradiction:
Improveparallel processing capacityVSAvoiddata reliability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The detection system is segmented into multiple independent areas, each containing both donor and acceptor control nucleic acids. This segmentation allows each area to independently monitor for cross-contamination, enabling parallel processing while maintaining data reliability through localized control mechanisms.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Control nucleic acids serve as intermediary elements that detect cross-contamination events. The donor control nucleic acid in one area can bind to the acceptor control nucleic acid in a neighboring area, acting as a molecular mediator that signals contamination without affecting the actual sample analysis.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If donor control nucleic acid is non-covalently attached to the carrier, then ease of manufacture is improved, but the donor control nucleic acid may be washed out causing loss of substance

Engineering Contradiction:
Improveattachment method simplicityVSAvoiddonor control nucleic acid retention
Core Design Contradiction:
Ease of manufactureVSLoss of substance

Solution Approach 1:

The non-covalent attachment, which initially appears to be a disadvantage due to potential washout, is converted into a benefit. The donor control nucleic acid is designed to be soluble and washable, allowing it to be removed from its original area and bind to acceptor control nucleic acid in neighboring contaminated areas, thereby detecting cross-contamination.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Stability of the object's composition

If acceptor control nucleic acid is covalently attached to the carrier, then stability of composition is improved, but device complexity increases due to different attachment methods

Engineering Contradiction:
Improveacceptor control nucleic acid stabilityVSAvoidattachment method diversity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

Different attachment methods are applied locally to different components: acceptor control nucleic acids are covalently attached to ensure stability and prevent washout, while donor control nucleic acids are non-covalently attached to allow solubility and mobility. This local differentiation of attachment properties optimizes the function of each component.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system effectively detects cross-contamination during sample application and subsequent washing steps, ensuring reliable data by distinguishing between contaminated and non-contaminated areas.

Implementation Method 1

The acceptor control nucleic acid and the donor control nucleic acid of alternating areas can bind to each other

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS12351861B2Cross-contamination control
Publication Date: 2025.07.08 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA
  • US12351861B2 patent drawing
  • US12351861B2 patent drawing
  • US12351861B2 patent drawing

AI summary

A nucleic acid or peptide detection system that includes a carrier with at least two areas is provided. A method and kit that use and/or include the nucleic acid peptide detection system are also provided.